Considering the molecular properties of kallistatin and the results of various kallistatin-related studies in the literature, we formulated our hypothesis for this study by relating kallistatin to the pathogenesis of PCOS. This evidence concerns the gene SERPINA4 and polycystic ovary syndrome.